By Erin Marie Daly ( March 18, 2010, 1:28 PM EDT) -- In a move designed to help drive its growth in key European markets, Teva Pharmaceutical Industries Ltd. has agreed to fork over $4.93 billion to acquire Ratiopharm GmbH, Germany's second-largest generics maker and the sixth-largest generic-drug company worldwide....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.